Journal profile · PHARMACOLOGY & PHARMACY
Clinical Pharmacology in Drug Development
ISSN 2160-7648 · Wiley-Blackwell · UNITED STATES
Clinical Pharmacology in Drug Development: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.64; hybrid open access; APC about USD 3,800; median 87 days to acceptance (85 articles, last 24 months); acceptance rate 51% (journal website); 153 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical Pharmacology in Drug Development is published by Wiley-Blackwell and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical studies and practices, Pharmacogenetics and Drug Metabolism and Diabetes Treatment and Management, together about 25.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
<em>Clinical Pharmacology in Drug Development</em> is a global, peer-reviewed journal publishing clinical pharmacology studies in drug development.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Amalia M. IssaPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical studies and practicesMedicine11.6%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics8.3%
- Diabetes Treatment and ManagementMedicine5.8%
- Drug Transport and Resistance MechanismsMedicine5.1%
- Chronic Lymphocytic Leukemia ResearchMedicine5%
- HIV/AIDS drug development and treatmentMedicine4.8%
- Pharmacological Effects and Toxicity StudiesMedicine4.2%
- Antibiotics Pharmacokinetics and EfficacyMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.64LetPub ·
- Impact factor (publisher) 2025
- 1.7Publisher website ·
- CiteScore 2026-06
- 3.4LetPub ·
- CiteScore (publisher) 2025
- 3.4Publisher website ·
- SJR 2026-06
- 0.55LetPub ·
- SNIP 2026-06
- 0.6LetPub ·
- h-index
- 16LetPub ·
- h-index
- 46OpenAlex ·
- i10-index
- 464OpenAlex ·
- 2-year mean citedness
- 1.49OpenAlex ·
- Self-citation rate
- 5.9%LetPub ·
- Share of gold OA articles
- 47.75%LetPub ·
Volume
- Articles per year
- 117LetPub ·
- Articles per year (publisher) 2025
- 125Publisher website ·
- Downloads per year (publisher) 2025
- 380,910Publisher website ·
Articles by year OpenAlex count · 1,741 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 108 | 68 | 28 |
| 2025 | 153 | 88 | 157 |
| 2024 | 154 | 95 | 435 |
| 2023 | 151 | 98 | 660 |
| 2022 | 174 | 86 | 1,056 |
| 2021 | 163 | 82 | 1,401 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
87 daysMedian, submission to acceptance · P25–P75 58 days – 135 days
- Acceptance to online
- median 33 days (85 articles)
- Submission to online
- median 128 days
- Sample
- 85 articles with submission and acceptance dates (265 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher) 2025
- 51%Publisher website ·
- Submission to first decision 2025
- 10 daysPublisher website ·
- Submission to acceptance 2025
- 76 daysPublisher website ·
- Acceptance to publication 2025
- 38 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,800 / EUR 3,170 / GBP 2,560 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 2160-7648
- Print ISSN
- 2160-763X
- Latest issue on the website
- Volume 15, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Clinical Pharmacology in Drug Development
What CAS zone is Clinical Pharmacology in Drug Development in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Pharmacology in Drug Development is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Pharmacology in Drug Development?
The latest impact factor listed by LetPub is 1.64; CiteScore 3.4, h-index 46.
How long does peer review take at Clinical Pharmacology in Drug Development?
Based on the dates recorded on 85 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 87 days (interquartile range 58–135 days); the journal's website gives an acceptance rate of 51% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Clinical Pharmacology in Drug Development?
According to LetPub and DOAJ records, Clinical Pharmacology in Drug Development is indexed in SCIE and Scopus.
Is Clinical Pharmacology in Drug Development open access, and what is the APC?
Clinical Pharmacology in Drug Development is a hybrid journal. For open-access publication: APC about USD 3,800.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .